Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Nicholas J. DePolo is active.

Publication


Featured researches published by Nicholas J. DePolo.


Molecular Therapy | 2000

VSV-G Pseudotyped Lentiviral Vector Particles Produced in Human Cells Are Inactivated by Human Serum

Nicholas J. DePolo; Joyce D. Reed; Philip Lee Sheridan; Kay Townsend; Sybille L. Sauter; Douglas J. Jolly; Thomas W. Dubensky


Archive | 1997

Crossless retroviral vectors

James G. Respess; Nicholas J. DePolo; Sunil Chada; Sybille L. Sauter; Mordechai Bodner; David A. Driver


Molecular Therapy | 2000

Generation of Retroviral Packaging and Producer Cell Lines for Large-Scale Vector Production and Clinical Application: Improved Safety and High Titer

Philip Lee Sheridan; Mordechai Bodner; Andrea Lynn; Trung K. Phuong; Nicholas J. DePolo; Daniel J. de la Vega; Joanne O'Dea; Kathy Nguyen; James E. McCormack; David A. Driver; Kay Townsend; Carlos E. Ibanez; Nancy Sajjadi; Judith S. Greengard; Margaret Dow Moore; James G. Respess; Stephen M. W. Chang; Thomas W. Dubensky; Douglas J. Jolly; Sybille L. Sauter


Journal of Virology | 1999

The Resistance of Retroviral Vectors Produced from Human Cells to Serum Inactivation In Vivo and In Vitro Is Primate Species Dependent

Nicholas J. DePolo; Cataline E. Harkleroad; Mordechai Bodner; Andrew T. Watt; Carol G. Anderson; Judith S. Greengard; Krishna K. Murthy; Thomas W. Dubensky; Douglas J. Jolly


Archive | 1997

Methods for administration of recombinant gene delivery vehicles for treatment of hemophilia and other disorders

Douglas J. Jolly; Stephen M. W. Chang; James G. Respess; Nicholas J. DePolo; David Chi-Tang Hsu; Carlos E. Ibanez; Judith S. Greengard; Lee Will


Human Gene Therapy | 1997

Anti-Vector Immunoglobulin Induced by Retroviral Vectors

James E. McCormack; Darlene Martineau; Nicholas J. DePolo; Stephanie Maifert; Leila Akbarian; Kay Townsend; Will Lee; Michael J. Irwin; Nancy Sajjadi; Douglas J. Jolly; John F. Warner


Human Gene Therapy | 1997

Evaluation of PCR and ELISA Assays for Screening Clinical Trial Subjects for Replication-Competent Retrovirus

Darlene Martineau; Wolfgang M. Klump; James E. McCormack; Nicholas J. DePolo; Edgar Kamantigue; Mary Petrowski; James Hanlon; Douglas J. Jolly; Steven J. Mento; Nancy Sajjadi


Archive | 1997

Methods for administration of recombinant gene delivery vehicles for treatment of hemophilia

Douglas J. Jolly; Jack R. Barber; Stephen M. W. Chang; James G. Respess; John R. Allen; Mordechai Boder; Kimberly Chong; La Vega Dan De; Nicholas J. DePolo; David Chi-Tang Hsu; Carlos E. Ibanez; Denice M. Mittelstaedt; Charles E. Prussak; Judith S. Greengard


Archive | 2000

Methods for producing a vector producing cell line utilizing a high multiplicity of transduction

Philip Lee Sheridan; Mordechai Bodner; Nicholas J. DePolo; Sybille L. Sauter; Stephen M. W. Chang


Archive | 1995

Production and administration of high titer recombinant retroviruses

Douglas J. Jolly; Jack R. Barber; Stephen M. W. Chang; James G. Respess; John R. Allen; Mordechai Bodner; Kimberly Chong; La Vega Dan De; Nicholas J. DePolo; David Chi-Tang Hsu; Carlos E. Ibanez; Denice M. Mittelstaedt; Charles E. Prussak

Collaboration


Dive into the Nicholas J. DePolo's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Carlos E. Ibanez

Scripps Research Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge